- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2020-10-28
2026-12-31
2027-12-31
200
NCT04592393
Seoul National University Hospital
Seoul National University Hospital
INTERVENTIONAL
Pancreas Cancer Surveillance Using an Abbreviated MRI
This study aims to establish a prospective cohort of developing pancreas cancer and surveillance MRI protocol. With the focused surveillance protocol, we perform surveillance for pancreas cancer for five years to estimate the risk of pancreas cancer and the clinical feasibility of the surveillance MRI.
N/A
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2020-10-07 | N/A | 2023-08-16 |
2020-10-16 | N/A | 2023-08-18 |
2020-10-19 | N/A | 2023-08 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
Screening
Allocation:
Na
Interventional Model:
Single Group
Masking:
None
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| EXPERIMENTAL: Abbreviated PB MRI Short and Focused non-contrast MRI for surveillance | DIAGNOSTIC_TEST: Abbreviated PB MRI
GENETIC: Gene mutation test
DIAGNOSTIC_TEST: Conventional follow-up
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Detection of pancreas cancer | number of detected pancreas cancer (resectable & BRPC only) in surveillance MRI. | 1 year after the last surveillance MRI. |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Scan time of abbreviated PB MRI for surveillance | table time, in-room time measurement for feasibility | 1 month after the first surveillance MRI. |
| Estimation of pancreas cancer risk | rate of developing pancreas cancer during the study period | 1 year after the last surveillance MRI. |
| Detection of pancreas cancer | number of detected pancreas cancer of all stages (resectable, BRPC, LAPC, metastatic) in surveillance MRI. | 1 year after the last surveillance MRI. |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
50 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
